Bristol-Myers Squibb welcomes opportunities that enhance or support our pipeline of products to address unmet medical needs in serious disease areas. In particular, we are looking for the following:

• New chemical entities and new molecular entities with an emphasis on later stage therapeutic opportunities;
• Research partnerships and collaborations;
• Drug discovery and development technologies.
• Opportunities to expand access to our medicines.
• Commercial expansion, we seek innovative ways of bringing our medicines to all parts of the globe.

Our Focus on Key Disease Areas

• Migrate into cardiology adjacencies
• Build the Alzheimer’s portfolio
• Expand immuno-science
• Sustain the HIV franchise
• Expand hematologic malignancies
• Build on solid tumor capability
• Expand the hepatitis C virus portfolio
• Migrate into cognition
• Leverage psychiatric franchise
• Expand into neuropathic pain
• Build a major metabolic capability
• Explore other areas of significant medical and commercial need

Drug Discovery & Development Technologies

Disease biology

• Systems biology
• Pathway analysis

Novel target identification

• Genetics
• Genomic sequencing
• Proteomics
• Bioinformatics

Target validation

• Transgenic animals
• siRNA
• Kinase assays

Assay development

• High content screening
• Kinase assays

High throughput screening

• Dye markers
• High throughput crystallography

Medicinal chemistry

• Novel chemistry
• Compound libraries

Preclinical development

• Microfluidic absorption, distribution, metabolism & excretion
• Protein expression

Formulations

• Solubility
• Biologic delivery systems
• Sustained release

Clinical trials

• Surrogate biomarkers
• Toxicogenomics
• Pharmacodiagnostics
• Imaging

Life cycle management

• Counterfeit detection

When contacting us, please provide a concise non-confidential data package, including the strengths of your discovery and its value within the competitive landscape. Contact us at StrategicTransactionsGroup@bms.com.